Skov J, Dejgaard A, Frkir J, Holst JJ, Jonassen T, Rittig S, et al
The subcutaneous conversion, combination pipeline, and new indication filings are Mercks primary defenses
Real-time logging immediately after eating improves accuracy and helps recognize satiety signals before overeating, as tirzepatide's delayed gastric emptying can cause sudden fullness
12 Although larger-scale studies are yet to explore the effects of GLP-1 RAs on cardiac structure and function, available evidence suggests that GLP-1 RAs may improve systolic and diastolic function in individuals with T2D who are at high risk of CVD and reduce infarct size after acute MI
Cortisol inhibits insulin release and reduces GLP-1 production and thereby also insulin secretion ( Figure 1 )
Future directions Future research should explore combination strategies, including dual and triple therapy regimens pairing tirzepatide with other agents including sodium-glucose cotransporter-2 inhibitors and the non-steroidal mineralocorticoid receptor antagonist, finerenone, which have been shown to offer additive cardiorenal protection alongside GLP-1RAs [35]
:max_bytes(150000):strip_icc()/nicotine-addiction-101-2825018zhansentexteditcopy-8dc8cdd855104de4b3fc4c138c31bde6.jpg)
